T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$8.01B |
| 2 |
Amazon
AMZN
|
+$5.64B |
| 3 |
Danaher
DHR
|
+$4.2B |
| 4 |
Gilead Sciences
GILD
|
+$4.09B |
| 5 |
JPMorgan Chase
JPM
|
+$4.03B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 13.97% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 11.58% |
| 5 | Technology | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Travelers Companies
TRV
$78.3B
| $174M | 0.05% |
+2,182,172
| New | +$183M |
|
427
Pacira BioSciences
PCRX
$972M
| $173M | 0.05% |
+5,964,703
| New | +$173M |
|
428
Sensata Technologies
ST
$6.73B
| $172M | 0.05% |
+4,914,600
| New | +$168M |
|
429
Angi Inc
ANGI
$182M
| $170M | 0.05% |
+640,353
| New | +$149M |
|
|
ELN
430
DELISTED
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
| $170M | 0.05% |
+12,011,507
| New | +$149M |
|
431
Kimco Realty
KIM
$16.1B
| $169M | 0.05% |
+7,907,170
| New | +$181M |
|
432
Air Products & Chemicals
APD
$68.9B
| $167M | 0.04% |
+1,975,745
| New | +$166M |
|
433
Check Point Software Technologies
CHKP
$13.2B
| $167M | 0.04% |
+3,358,700
| New | +$162M |
|
434
Wolfspeed
WOLF
$1.57B
| $166M | 0.04% |
+2,596,060
| New | +$152M |
|
435
Texas Capital Bancshares
TCBI
$4.36B
| $165M | 0.04% |
+3,714,320
| New | +$159M |
|
436
Five Below
FIVE
$13B
| $164M | 0.04% |
+4,472,650
| New | +$167M |
|
437
Keurig Dr Pepper
KDP
$39.7B
| $164M | 0.04% |
+3,579,070
| New | +$170M |
|
|
WRI
438
DELISTED
Weingarten Realty Investors
WRI
| $164M | 0.04% |
+5,338,084
| New | +$174M |
|
439
BioMarin Pharmaceuticals
BMRN
$13.5B
| $164M | 0.04% |
+2,941,290
| New | +$183M |
|
440
Essex Property Trust
ESS
$18.2B
| $164M | 0.04% |
+1,032,563
| New | +$163M |
|
441
Packaging Corp of America
PKG
$22.9B
| $163M | 0.04% |
+3,336,555
| New | +$159M |
|
442
Wabtec
WAB
$50.3B
| $163M | 0.04% |
+3,045,430
| New | +$160M |
|
|
ARUN
443
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $161M | 0.04% |
+10,512,229
| New | +$190M |
|
444
Edgewell Personal Care
EPC
$1.32B
| $161M | 0.04% |
+2,160,370
| New | +$157M |
|
|
LCC
445
DELISTED
US AIRWAYS GROUP INC.
LCC
| $160M | 0.04% |
+9,754,596
| New | +$165M |
|
446
RBC Bearings
RBC
$17.5B
| $160M | 0.04% |
+3,071,700
| New | +$151M |
|
447
Teleflex
TFX
$5.91B
| $159M | 0.04% |
+2,045,930
| New | +$164M |
|
448
Enpro
NPO
$7.12B
| $158M | 0.04% |
+3,122,158
| New | +$155M |
|
|
MOLXA
449
DELISTED
MOLEX INC CL-A
MOLXA
| $157M | 0.04% |
+6,333,427
| New | +$157M |
|
450
EastGroup Properties
EGP
$10.8B
| $157M | 0.04% |
+2,796,382
| New | +$169M |
|
Similar funds
T. Rowe Price Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for T. Rowe Price Associates, which disclosed 2,429 positions worth $374B. Its ten largest holdings account for 12% of the portfolio.
Its largest position is Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2013 buy was Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $374B portfolio in Q2 2013.
- T. Rowe Price Associates disclosed 2,429 positions in Q2 2013, its first 13F filing on record.
Based on T. Rowe Price Associates's 13F filing for Q2 2013, filed 14 Aug 2013.